Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia

Table 2 Characteristics of MCI non-convertors and convertors in three years follow-up

Demographics	MCI-nc (n = 62)	MCI-c (n = 16)	p value
Age, y	68.3 (4.1)	68.5 (3.8)	0.844
Sex
Female	34 (55%)	9 (56%)	0.919
Male	28 (45%)	7 (44%)	0.919
Education duration, y	10.4 (2.7)	10.3 (1.9)	0.953
ApoE ε4 carrier
(+)	10 (16%)	4 (25%)	0.410
(−)	52 (84%)	12 (75%)	0.410
MMSE	25.8 (1.4)	19.3 (1.7)	0.000
MoCA	22.3 (1.7)	14.5 (1.5)	0.000
ADAS-cog	19.2 (3.6)	30.0 (3.3)	0.000
AVLT-SR	5.7 (1.4)	2.8 (1.3)	0.000
AVLT-LR	4.1 (1.3)	1.5 (1.0)	0.000

Abbreviations: MMSE Mini Mental State Examination, MoCA Montreal Cognitive Assessment, ADAS-cog Alzheimer’s Disease Assessment Scale-cognitive subscale, AVLT Auditory Verbal Learning test, MCI-nc not converted from MCI to AD dementia, MCI-c converted from MCI to AD dementia

ISSN: 2047-9158